Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global
Investment Conference
MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp.
(Nasdaq: MEMY) today announced that Michael Smith, Chief Financial Officer and
Head of Business Development, will provide a company update at the Rodman &
Renshaw Annual Global Investment Conference on Tuesday, November 11, 2008 at
11:10 a.m. EST at the New York Palace Hotel, in New York City.
Interested parties may access the live webcast of the presentation by visiting
the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com. Archived versions of the webcast will be
available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders,
many of which exhibit significant impairment of memory and other cognitive
functions, including Alzheimer's disease and schizophrenia. For additional
information, please visit our website at http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
Jzaneen Lalani, General Counsel of Memory Pharmaceuticals Corp.,
+1-201-802-7249; or Laura Perry of LMP Investor Relations Inc.,
+1-646-719-1055, of Memory Pharmaceuticals Corp.
